Ah, living the good life. Or should I say living the good and long life. That's what many more dogs will be doing these days thanks to Pfizer Animal Health (PAH) and their recently FDA-approved canine cancer therapy drug, Palladia™.
Palladia™ was developed to treat mast cell tumors (MCT) in dogs and is the industry's first and only drug to be specifically approved for the treatment of canine cancer. So, I'd say this is doggone good news for both dogs and their people!
Mast cell tumors are specialized cells that are normally involved in the process of inflammation, such as allergic responses, tissue growth and wound healing. Typically, MCT appears in the form of skin swelling or red, itchy lumps of various shapes and sizes. It's important to note they can mimic other more common skin conditions and can only be diagnosed through a biopsy.
This is a very, very important topic and something all dog owners should learn more about. As I'm not the expert here, I would suggest reading the full article at http://webvet.com/main/article?id=2222 and also the press release issued by the FDA. It's exciting news and it's a treatment that is sure to enhance the lives of both dogs and humans by helping us keep our beloved pets happy and healthy for as long dogly possible.
So kudos to the folks at Pfizer Animal Health and everyone who was involved in the development of this ground-breaking drug!!